Literature DB >> 36261455

Development of a functional composite for the evaluation of spinal and bulbar muscular atrophy.

Tomonori Inagaki1, Atsushi Hashizume2,3, Yasuhiro Hijikata1, Shinichiro Yamada1, Daisuke Ito1, Yoshiyuki Kishimoto1, Ryota Torii1, Hiroyuki Sato4, Akihiro Hirakawa4, Masahisa Katsuno5,6.   

Abstract

This study aimed to develop a functional measurement that combines quantitative motor evaluation index of various body regions in patients with spinal and bulbar muscular atrophy (SBMA). We assessed subjects with SBMA and healthy controls with quantitative muscle strength measurements and functional scales. We selected tongue pressure, grip power, % peak expiratory flow (%PEF), timed walking test, and % forced vital capacity (%FVC) as components. By combining these values with Z-score, we created a functional composite (SBMA functional composite: SBMAFC). We also calculated the standardized response mean to compare the sensitivity of SBMAFC with that of existing measurements. A total of 97 genetically confirmed patients with SBMA and 36 age- and sex-matched healthy controls were enrolled. In the longitudinal analysis, the standardized response mean of SBMAFC was larger than that of existing rating scales. Receiver operating characteristic (ROC) analysis demonstrated that the SBMAFC is capable of distinguishing between subjects with early-stage SBMA and healthy controls. SBMAFC is more sensitive to disease progression than existing functional rating scales and is a potential outcome measure in clinical trials of SBMA.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 36261455      PMCID: PMC9581920          DOI: 10.1038/s41598-022-22322-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  44 in total

1.  Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age.

Authors:  E BERGLUND; G BIRATH; J BJURE; G GRIMBY; I KJELLMER; L SANDQVIST; B SODERHOLM
Journal:  Acta Med Scand       Date:  1963-02

2.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; E M Wilson; D B Lubahn; A E Harding; K H Fischbeck
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

3.  Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients.

Authors:  Naoki Atsuta; Hirohisa Watanabe; Mizuki Ito; Haruhiko Banno; Keisuke Suzuki; Masahisa Katsuno; Fumiaki Tanaka; Akiko Tamakoshi; Gen Sobue
Journal:  Brain       Date:  2006-04-18       Impact factor: 13.501

4.  Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial.

Authors:  Lindsay E Fernández-Rhodes; Angela D Kokkinis; Michelle J White; Charlotte A Watts; Sungyoung Auh; Neal O Jeffries; Joseph A Shrader; Tanya J Lehky; Li Li; Jennifer E Ryder; Ellen W Levy; Beth I Solomon; Michael O Harris-Love; Alison La Pean; Alice B Schindler; Cheunju Chen; Nicholas A Di Prospero; Kenneth H Fischbeck
Journal:  Lancet Neurol       Date:  2011-01-06       Impact factor: 44.182

5.  A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study.

Authors:  Atsushi Hashizume; Masahisa Katsuno; Keisuke Suzuki; Haruhiko Banno; Noriaki Suga; Tomoo Mano; Amane Araki; Yasuhiro Hijikata; Christopher Grunseich; Angela Kokkinis; Akihiro Hirakawa; Hirohisa Watanabe; Masahiko Yamamoto; Kenneth H Fischbeck; Gen Sobue
Journal:  Neuromuscul Disord       Date:  2015-03-20       Impact factor: 4.296

6.  The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy.

Authors:  Keisuke Suzuki; Masahisa Katsuno; Haruhiko Banno; Yu Takeuchi; Motoshi Kawashima; Noriaki Suga; Atsushi Hashizume; Tetsuo Hama; Kei Uchida; Fumitada Yamashita; Tomohiko Nakamura; Masaaki Hirayama; Fumiaki Tanaka; Gen Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-12-03       Impact factor: 10.154

Review 7.  Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).

Authors:  Masahisa Katsuno; Hiroaki Adachi; Masahiro Waza; Haruhiko Banno; Keisuke Suzuki; Fumiaki Tanaka; Manabu Doyu; Gen Sobue
Journal:  Exp Neurol       Date:  2006-03-02       Impact factor: 5.330

8.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

9.  Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy.

Authors:  Yu Takeuchi; Masahisa Katsuno; Haruhiko Banno; Keisuke Suzuki; Motoshi Kawashima; Naoki Atsuta; Mizuki Ito; Hirohisa Watanabe; Fumiaki Tanaka; Gen Sobue
Journal:  Muscle Nerve       Date:  2008-08       Impact factor: 3.217

Review 10.  Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis.

Authors:  Sandra Meyer-Moock; You-Shan Feng; Mathias Maeurer; Franz-Werner Dippel; Thomas Kohlmann
Journal:  BMC Neurol       Date:  2014-03-25       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.